Spinal Muscular Atrophy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Your child has been confirmed through genetic testing to have SMA (Spinal Muscular Atrophy), their SMN2 copy number is known, and they were identified through newborn screening, family screening, or found to have the condition before showing any symptoms — and they are either already receiving treatment or have 4 copies of the SMN2 gene (which may allow for observation only)
- Your child has been confirmed through genetic testing to have DMD (Duchenne Muscular Dystrophy), was identified through newborn screening, family screening, or found to have the condition before showing any symptoms, and is under 4 years old at the time of joining the trial
- The parent or legal guardian is able to give informed consent on behalf of the child
Who may not be able to join:
- The child has any other health condition (short-term or long-term) that the trial doctor believes could interfere with the assessments or the child's physical development
- The child is already participating in another clinical trial involving a treatment or therapy
- The family does not have access to an internet connection at home
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Tamara Dangouloff, PhD, University of Liege
Phone: +33662438138
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Digital Mobility Monitoring Compliance; Digital Mobility Monitoring Compliance; Digital Mobility Monitoring Compliance; Digital Mobility Monitoring Compliance; Walking Pattern Characteristics; Walking Pattern Characteristics; Walking Pattern Characteristics; Reliability; Group Differences in Digital Variables
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.